SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending after announcing a non-exclusive license agreement with Pfizer for its Matrix-M adjuvant, providing significant validation for the technology. This deal, building on previous collaborations, is driving community excitement and fueling discussions about the adjuvant's potential applications and the company's future partnerships amidst notable short interest.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is driving significant conversation as escalating US-EU trade tensions, particularly over Greenland and proposed tariffs, spark widespread market uncertainty and a risk-off shift. The community is sharply divided, with intense debate over whether current volatility signals a deeper correction or presents a key buying opportunity amidst ongoing institutional interest and broader macroeconomic shifts.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is generating significant buzz following positive regulatory advancements for its ANKTIVA therapy, with the FDA outlining a path to resubmission for papillary bladder cancer that requires no new clinical trials. This news, combined with recent international approvals, is fueling strong community sentiment around the potential for a "cancer cure" and intense discussions anticipating a substantial short squeeze.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is currently experiencing a significant surge, fueled by an intense Arctic air invasion across the United States that is driving up natural gas demand and futures prices. The strong upward momentum has triggered a notable short squeeze, with the community actively discussing substantial profits and anticipating continued upside as extreme cold weather is projected to persist. This volatility is characteristic of the 2x leveraged ETF, attracting both profit-takers and those eyeing further gains.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is currently a major talking point among investors, primarily driven by its upcoming earnings report and the proposed all-cash acquisition of Warner Bros. Discovery assets, which has sparked a debate over potential growth versus debt concerns. The community is closely watching for strong ad-tier performance and subscriber metrics, particularly after a previous tax-related earnings miss, with sentiment split on whether recent oversold conditions signal a significant rebound or continued volatility.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending as market participants react to heightened geopolitical tensions, specifically former President Trump's recent tariff threats against NATO allies over Greenland and an anticipated Supreme Court ruling on presidential tariff authority. This has sparked a fierce debate among investors, with some advocating to "buy the dip" and anticipating a rapid "Taco Trade" rebound, while others warn of a significant market correction. Adding to the volatility are concerns surrounding Japan's bond market instability, creating a complex and uncertain trading environment.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is experiencing significant volatility amid escalating geopolitical tensions, notably the US asserting control over Venezuela's oil and ongoing debates surrounding US tariffs, fueling a "flight to quality" narrative for some. The community is actively discussing whether these events, alongside large institutional bond purchases, will continue to boost Treasuries as a safe haven or intensify concerns over US debt and the Federal Reserve's independence.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin ($APP) is experiencing significant volatility and a notable price decline following a new short report alleging the company's involvement in money laundering. This report has sparked intense debate among investors, with many attributing the drop to market manipulation and viewing it as a buying opportunity, while others express concern over the serious accusations despite recent bullish analyst upgrades.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending due to overwhelmingly positive data from its Phase 1 clinical trial of soquelitinib for atopic dermatitis, with community discussions highlighting its strong efficacy in treatment-resistant patients. Investors are actively debating the potential for this novel oral ITK inhibitor to disrupt the significant atopic dermatitis market, fueling speculation of future partnerships or an acquisition and validating its broader immune-modulating platform.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is trending as natural gas prices sharply reverse, primarily driven by dramatically warmer weather forecasts that are erasing previous cold-snap gains. The community is actively discussing the extreme volatility and "widow maker" nature of natural gas ETFs, with many attempting to capitalize on KOLD's rapid ascent amidst widespread price uncertainty. This significant shift in winter weather expectations is compelling traders to adjust positions, leading to rapid price movements in inverse natural gas products.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Churchill Capital Corp X (NASDAQ:CCCX) Short Interest Update

Churchill Capital Corp X (NASDAQ:CCCX - Get Free Report) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totaling 696,567 shares, a growth...

Former Royal Air Force Deputy Force Commander Colin Sullivan MBE Joins Infleqtion as Managing Director, UK

Infleqtion (the Company), a global leader in neutral atom-based quantum technology, announced the appointment of Colin Sullivan MBE as Managing Director of Infleqtion UK effective immediately. In...

Churchill Capital Corp X (NASDAQ:CCCX) Trading Down 7% - Time to Sell?

Churchill Capital Corp X (NASDAQ:CCCX) Stock Price Down 7% - What's Next...

Infleqtion and Churchill Capital Corp X Announce Filing of Registration Statement on Form S-4 in Connection with Proposed Business Combination

Infleqtion, a global leader in neutral-atombased quantum technology, and Churchill Capital Corp X (NASDAQ: CCCX), a publicly traded special purpose acquisition company, today announced the filing...

Churchill Capital Corp X (NASDAQ:CCCX) Trading Down 3.8% - Here's What Happened

Churchill Capital Corp X (NASDAQ:CCCX) Stock Price Down 3.8% - Here's What Happened...

Infleqtion Presents on Real-World Applications of Quantum Sensing at CES 2026

Infleqtion, a global leader in neutral atombased quantum technology, will participate in the quantum conference track at CES 2026, taking place January 7-10 in Las Vegas. [As the world's most...

Churchill Capital Corp X (NASDAQ:CCCX) Shares Gap Down - Here's What Happened

Churchill Capital Corp X (NASDAQ:CCCX) Shares Gap Down - Here's What Happened...

Churchill Capital Corp X (NASDAQ:CCCX) Shares Gap Up - Still a Buy?

Churchill Capital Corp X (NASDAQ:CCCX) Shares Gap Up - Here's What Happened...

<ul class="summary-bullets"><li>Quantum stocks have resumed their rally on renewed institutional validation and retail optimism, even as price swings remain pronounced.</li><li>With scalability and commercialization timelines still uncertain, gains are likely to favor companies that demonstrate more precise execution and stronger strategic partnerships.</li><li>A majority of retail traders are bullish despite the volatility and mixed fundamentals.</li></ul>Quantum computing stocks are surging sharply again, even in the absence of any major industry-shaking news. The renewed enthusiasm seems to be driven less by hard catalysts and more by anticipation, with investors looking ahead to the Consumer Electronics Show 2026, set to kick off on Jan. 6.Adding a spark to the optimism,<a href="https://stocktwits.com/symbol/QBTS">&nbsp;D-Wave Computing</a> said its quantum technology evangelist, Murray Thom, will take the CES stage to showcase a live demo of the company’s award-winning systems, alongside real-world customer success stories, a signal that quantum's promise is inching closer to practical application.Skepticism around the technology’s near-term commercial impact still lingers, but that hasn’t stopped investors from piling into the sector. Most smaller publicly traded quantum companies are now on track for a second straight year of gains. The rally in 2024 was nothing short of spectacular, led by D-Wave, whose shares skyrocketed by more than 1,600%, with much of that surge packed into the final two months of the year.<img src="https://news.stocktwits-cdn.com/QC_2024_gains_png_f17a7c5f0d.webp" alt="QC2024 gains.png">Source: KoyfinThe rally stalled at the start of the year, with most, barring D-Wave, trading in the red until mid-to-early September. Thanks to a recovery, catalyzed by Wall Street’s acknowledgment of the technology’s relevance, and some company-specific updates, the quantum rally reignited. The move since then, however, has been interspersed by pullbacks and recoveries, and the gains haven’t been across the board.<img src="https://news.stocktwits-cdn.com/QC_stock_2025_png_03bb66df16.webp" alt="QC stock 2025.png">Source: Koyfin<h2 class="st-heading-2">Retail Upbeat Rally Will Continue</h2>Despite the volatility in quantum stocks, retail traders largely brace for more gains. An ongoing Stocktwits poll that asked retail users of the platform, “How Will Quantum Computing Stocks Perform in 2026?” found that a majority (51%) expect “strong gains across the sector.” But the view isn’t unanimous. Among the respondents, 13% called for a “sharp decline &amp; reset,” while 7% foresaw flattish performance.A sizeable proportion (29%) of respondents bracing for “selecting, winners, mixed results.” If that is the case, investors are left to contend with the question of which ones will outperform and which will lag.<h2 class="st-heading-2">Drawing Strategic Spotlight</h2>Before assessing specific stocks, here’s Wall Street’s crystal-ball view of the industry.The strongest validation from Wall Street firms came in the form of a key development. JPMorgan included quantum computing in the list of industries critical to the national economy. In a statement released in mid-October, the firm said it will make direct equity and venture capital investments of up to $10 billion to help select companies primarily in the United States enhance their growth, spur innovation, and accelerate strategic manufacturing.”&nbsp;Separately, Morgan Stanley disclosed a 7% stake in&nbsp;<a href="https://stocktwits.com/symbol/IONQ">IonQ</a> in August.&nbsp;The Trump administration also took cognizance of the industry's prospects and its critical nature. A Wall Street Journal report, citing sources, stated in late October that the government is mulling small investments in quantum computing names, although no confirmation has come yet.&nbsp;Privately held Quantinium, formed in 2021 through the merger of Cambridge Quantum Computing and Honeywell Quantum Solutions, was in the news following the unveiling of its Helios quantum computer. The company has also forged partnerships to foray into the Middle East, especially Qatar and the UAE.&nbsp;McKinsey estimates that quantum computing, quantum communication, and quantum sensing — the three pillars of the technology — would together generate up to $97 billion in worldwide revenue by 2035, a quantum leap from $4 billion in 2024.Matt Kinsella, CEO of Infleqtion, another privately held quantum computing name, which has agreed to merge with Churchill Capital Corp X (CCCX), a SPAC,&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/infleqtion-s-ceo-sees-industry-consolidation-160-b-opportunity/cLPQ4R0REEy">outlined</a> these multiple opportunities in an interview with Stocktwits in November. Infleqtion specializes in quantum sensors used in quantum clocks, RF antennas, gravimeters, and other inertial sensing equipment.<h2 class="st-heading-2">The Pushbacks&nbsp;</h2>The technology itself faces hurdles—including qubit instability, the need for fault-tolerant architectures, limited coherence times, and complex error-correction requirements—that continue to constrain scalability, practical applications, and reliability.&nbsp;Kinsella said the wait for commercially viable computers may not be far off. The executive said it might take until 2028 for Infleqtion to go to 100 logical qubits, which are error-corrected physical qubits.&nbsp; This is when quantum computers will begin to do what classical computers can’t do, he added.<h2 class="st-heading-2">Which is most profitable to buy?</h2>According to Koyfin, the upside potential relative to the average analyst price targets for the publicly listed names is as follows:<figure class="table" style="width:98.32%;"><table class="ck-table-resized"><colgroup><col style="width:32.02%;"><col style="width:10.84%;"><col style="width:10.09%;"><col style="width:16.02%;"><col style="width:31.03%;"></colgroup><tbody><tr><td>&nbsp;</td><td>Upside Potential</td><td>Analyst Coverage</td><td>Proportion of bullish analysts</td><td>Retail Sentiment*</td></tr><tr><td>D-Wave</td><td>+21%</td><td>14</td><td>93%</td><td>Bullish</td></tr><tr><td>IONQ</td><td>+39%</td><td>12</td><td>75%</td><td>Bullish</td></tr><tr><td>Rigetti</td><td>+42%</td><td>11</td><td>73%</td><td>Extremely bullish</td></tr><tr><td>Quantum Computing</td><td>+38%</td><td>4</td><td>50%</td><td>Neutral</td></tr></tbody></table></figure>*based on the Stocktwits sentiment meterWhile broad-based gains may prove elusive, select names with clearer commercialization pathways and strategic backing are likely to drive performance into 2026. It should be noted that these companies are up against big techs, some of which have amped up their bets on quantum computing. IBM, considered a pioneer, is still in the fray, while Microsoft and Alphabet have unveiled in-house quantum chips, and Google has launched an algorithm called “Quantum Echoes.”Infleqtion’s Kinsella also raised the possibility of an industry shakeout&nbsp;in the Stocktwits interview. “I think you'll probably end up with a handful of very large, very important quantum companies over the course of the next five to 10 years,” he said.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/how-amd-quietly-beat-nvidia-this-year-despite-china-curbs/cLepizeREuO">How AMD Quietly Beat Nvidia This Year — Even As China Curbs Hit Them Both</a>

Most smaller publicly traded quantum companies are now on track for a second straight year of gains.

The Quantum Trade Is Heating Up Again — And Retail Thinks 2026 Could Be The Real Payoff

Quantum computing stocks remain volatile and speculative, but rising institutional validation and sustained retail optimism suggest the sector’s rally still has legs.

QTUM, RGTI, QBTS Stocks Have A Santa Rally: Retail Thinks 2026 May Deliver Real Quantum Payoff 

Equity

Quantum computing stocks remain volatile and speculative, but rising institutional validation and sustained retail optimism suggest the sector’s rally still has legs.


Churchill Capital Corp X (NASDAQ:CCCX) Stock Price Up 11% - Time to Buy?

Churchill Capital Corp X (NASDAQ:CCCX) Stock Price Up 11% - Here's Why...

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

CCCX
Churchill Capital Corp X

Feed

News

Sentiment

Fundamentals

Info

Latest CCCX News

CCCXChurchill Capital Corp X